Newsroom | 28429 results
Sorted by: Latest
-
Generational Group Advises Farabaugh Engineering & Testing Inc. in Its Sale to Certerra
DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Farabaugh Engineering & Testing Inc. to Certerra. The acquisition closed August 15, 2025. Headquartered in McKeesport, Pennsylvania, Farabaugh Engineering & Testing Inc. (FETLabs) is a family-owned, full-service engineering laboratory with more than 35 years of experience in the building components industry. The company provides...
-
BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB
SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“Company”), the largest privately owned operator of real estate for the life science and technology industries in the United States and the United Kingdom, today released its 2024 Sustainability Report, demonstrating continued industry leadership in sustainable development, decarbonization, community partnership, and responsible business operations. The report showcases how BioMed Realty’s tenant-first and vertically integrated model consistently provi...
-
Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces that Health Canada has accepted, without objection, the Clinical Trial Application (CTA) for COYA 302 for the treatment of amyotrophic lateral sclerosis (ALS). The CTA acceptance by Health Canada allows for activation of clinical sit...
-
VOKA Announces Free 1-Month Access to a Pro Subscription for New Users
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--VOKA provides one-month free access to VOKA 3D Anatomy & Pathology, a high-precision 3D atlas for medical education and clinical professionals....
-
Xcimer Energy Delivers Technical Update to U.S. Energy Sec. Chris Wright and U.S. Rep. Gabe Evans in Denver Laser Bay
DENVER--(BUSINESS WIRE)--Xcimer Energy Inc. welcomed U.S. Energy Sec. Chris Wright and U.S. Rep. Gabe Evans of Colorado to the company’s Denver laser bay on Monday for a technology briefing and update on its progress to commercialize laser fusion. Earlier this year, Xcimer completed the first key component of its prototype laser system. Just last week, the company began testing the highest-energy KrF laser built in the 21st century. This laser provides the optical energy to power the “Phoenix”...
-
Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India
AHMEDABAD, India--(BUSINESS WIRE)--Kashiv BioSciences Private Limited (“Kashiv”), a biopharmaceutical company, today announced that it has secured financing of INR 648 crore from the Union Bank of India. The proceeds will be used to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat. The new single-use commercial manufacturing facility will be one of India’s largest, equipped with cutting-edge technologies to support the production of high-quality biologics and...
-
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease
SUGAR LAND, Texas--(BUSINESS WIRE)--Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences’ allogeneic adipose‑derived mesenchymal stem cell therapy (HB-adMSCs) for patients with early to moderate Parkinson’s Disease (PD), a condition currently considered incurable that affects approximately one million in the U.S., with a projected global patient population of 25 mi...
-
RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue
LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a pilot clinical trial to examine the safety and efficacy of TETRANITE®, the company’s regenerative bone adhesive, to perform dental ridge augmentation procedures without the need for ancillary containment devices like membranes or meshes or fixation aids like tacks and screws. “The ability for the product to adhere to the surrounding bony walls of a site tha...
-
Infleqtion Chief Scientist for Quantum Information Dr. Mark Saffman Awarded the John Stewart Bell Prize
BOULDER, Colo.--(BUSINESS WIRE)--Infleqtion (the “Company”), a global leader in neutral atom-based quantum technology, announced that Chief Scientist for Quantum Information Dr. Mark Saffman was awarded the ninth Biennial John Stewart Bell Prize for Research on Fundamental Issues in Quantum Mechanics and Their Applications. His work underpins Infleqtion’s quantum computing roadmap as the company moves toward delivering fault-tolerant quantum systems critical for achieving quantum advantage and...
-
Applied BioCode Submits BioCode® Respiratory Pathogen Panel (RPP) with KingFisher™ Nucleic Acid Extraction Claim to the FDA
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System in combination with the BioCode® Respiratory Pathogen Panel (RPP). This submission is aimed at expanding the use of the BioCode® RPP, enabling laboratories to further streamline workflows while maintaining high-quality, reliable results. The new submission...